Real-time enrollment status for this adhd clinical trial
Current Status
Recruiting
Checked: October 20, 2026 at 8:50 AM UTC
| NCT Number | NCT07717892 |
| Recruiting Status | Recruiting |
| Condition | ADHD |
| Phase | PHASE3 |
| Target Enrollment | 468 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Axsome Therapeutics, Inc. |
| Last Updated on CT.gov | October 13, 2026 (1 week ago) |
As of October 20, 2026: Clinical trial NCT07717892 is currently recruiting participants. This phase3 study for adhd is actively seeking new participants at 28 locations across the United States. The study is sponsored by Axsome Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07717892 is actively recruiting participants as of October 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07717892 was last updated 1 week ago (October 13, 2026). HelloStudys verifies this status automatically.